OSR Holdings ROE 2023-2025 | OSRH
Current and historical return on equity (ROE) values for OSR Holdings (OSRH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OSR Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.01B | $0.13B | -15.15% |
| 2024-12-31 | $0.00B | $0.14B | -6.25% |
| 2024-09-30 | $0.00B | $-0.01B | 63.16% |
| 2024-06-30 | $0.00B | $-0.01B | 80.00% |
| 2024-03-31 | $0.00B | $0.00B | 100.00% |
| 2023-12-31 | $0.00B | $0.00B | 0.00% |
| 2023-09-30 | $0.00B | $0.00B | 0.00% |
| 2023-06-30 | $0.00B | $0.00B | 0.00% |
| 2023-03-31 | $0.00B | $0.00B | 0.00% |
| 2022-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.020B | $0.000B |
| Bellevue Life Sciences Acquisition Corp. is a blank check company. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Bellevue Life Sciences Acquisition Corp. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.024B | 25.89 |
| CVS Health (CVS) | United States | $80.885B | 10.05 |
| Elevance Health (ELV) | United States | $75.961B | 9.80 |
| Cencora (COR) | United States | $57.110B | 19.87 |
| DiDi Global (DIDIY) | China | $25.792B | 27.40 |
| Labcorp Holdings (LH) | United States | $20.561B | 16.68 |
| Natera (NTRA) | United States | $20.462B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.598B | 0.00 |
| CochLear (CHEOY) | Australia | $12.760B | 0.00 |
| Solventum (SOLV) | United States | $12.748B | 13.49 |
| ICON (ICLR) | Ireland | $11.757B | 10.93 |
| Revvity (RVTY) | United States | $11.304B | 19.45 |
| Viatris (VTRS) | United States | $10.481B | 3.60 |
| Medpace Holdings (MEDP) | United States | $8.988B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.788B | 0.00 |
| Avantor (AVTR) | United States | $8.736B | 12.69 |
| HealthEquity (HQY) | United States | $8.317B | 36.43 |
| Charles River Laboratories (CRL) | United States | $7.584B | 14.86 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.355B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 28.56 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.230B | 18.35 |
| Surgery Partners (SGRY) | United States | $2.799B | 36.40 |
| Alignment Healthcare (ALHC) | United States | $2.623B | 0.00 |
| Concentras Parent (CON) | United States | $2.543B | 14.70 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| GeneDx Holdings (WGS) | United States | $2.331B | 89.77 |
| Progyny (PGNY) | United States | $1.992B | 43.85 |
| Ardent Health (ARDT) | United States | $1.991B | 8.49 |
| PACS (PACS) | United States | $1.897B | 0.00 |
| Premier (PINC) | United States | $1.719B | 13.05 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Teladoc Health (TDOC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.285B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.100B | 8.37 |
| CareDx (CDNA) | United States | $1.058B | 16.53 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.761B | 7.13 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| InnovAge Holding (INNV) | United States | $0.564B | 0.00 |
| Embecta (EMBC) | United States | $0.560B | 3.77 |
| SBC Medicals (SBC) | United States | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.497B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.472B | 10.63 |
| Omada Health (OMDA) | $0.463B | 0.00 | |
| So-Young (SY) | China | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.354B | 29.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.333B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.265B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| Pheton Holdings (PTHL) | China | $0.136B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
| KindlyMD (NAKA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |